Skip to main content

ÍS
EN

Forsíða

Forsíða

Þorvarður Jón Löve - Professor

Þorvarður Jón Löve

–

School of Health Sciences

Þorvarður Jón Löve

Professor

Location
Sturlugata 8
Email
thl [at] hi.is

Unit
Faculty of Medicine

ORCID site
https://orcid.org/0000-0002-2680-6120
Research portal – Þorvarður Jón Löve
Under construction throughout the autumn semester 2023

Published works

2022

Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study.Rheumatology (Oxford, England)
The first wave of COVID-19 and concurrent social restrictions were not associated with a negative impact on mental health and psychiatric well-being.Journal of internal medicine
A Patients' Perspective Towards the Injection Devices for Humira® and Imraldi® in a Nationwide Switching Program.Frontiers in medicine
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting.The Journal of rheumatology
High Rate of Hepatitis C Virus Reinfection Among Recently Injecting Drug Users: Results From the TraP Hep C Program-A Prospective Nationwide, Population-Based Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.The Journal of rheumatology
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study.RMD open
Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogen. Rheumatology (Oxford, England)
Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance.Frontiers in immunology
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study.Blood cancer journal
Comment on: Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogen: reply.Rheumatology (Oxford, England)

2021

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration.Annals of the rheumatic diseases
Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study.The lancet. Gastroenterology & hepatology
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study.Rheumatology (Oxford, England)
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study.Rheumatology (Oxford, England)
Risk Factors for Diagnosis of Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and Ankylosing Spondylitis: A Set of Parallel Case-control Studies.The Journal of rheumatology
Does biologic therapy impact the development of PsA among patients with psoriasis?Annals of the rheumatic diseases
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study.Blood cancer journal
Validity of chronic disease diagnoses in Icelandic healthcare registries.Scandinavian journal of public health
Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic population.BMJ open
No One Will be Safe Until Our Children are Safe: Parent's Attitude Towards COVID-19 Childhood Immunization.The Pediatric infectious disease journal
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies.Blood cancer journal
Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries.Arthritis care & research
Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland.Annals of the rheumatic diseases
Outpatient Use of Antimicrobials in Patients With Rheumatoid Arthritis Before and After Treatment With Tumor Necrosis Factor Inhibitors: A Nationwide Retrospective Cohort Study.ACR open rheumatology

2020

FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease.Nature
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis.Rheumatology (Oxford, England)
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.Rheumatology (Oxford, England)
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance.European journal of haematology

2019

Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible.RMD open
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.Rheumatology (Oxford, England)

2018

Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study.European heart journal
Golimumab in the treatment of psoriatic arthritisExpert Review of Clinical Immunology
The majority of patients with psoriatic arthritis are not eligible for randomised clinical trials.Clinical and experimental rheumatology
Treatment as Prevention for Hepatitis C (TraP Hep C) - a nationwide elimination programme in Iceland using direct-acting antiviral agents.Journal of internal medicine
Infections and the risk of psoriatic arthritis among psoriasis patients: a systematic reviewRheumatology International

2017

The risk of fracture among patients with psoriatic arthritis and psoriasis: A population-based studyAnnals of the Rheumatic Diseases
Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasisAnnals of the Rheumatic Diseases
Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland.Open forum infectious diseases
Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritisRheumatology (United Kingdom)

2016

Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center studyAnnals of Hematology
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic ArthritisArthritis and Rheumatology
The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: Results from the DANBIO and ICEBIO registriesRheumatology (United Kingdom)

2015

Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: A population-based cohort studyAnnals of the Rheumatic Diseases

2014

Treatments for nail psoriasis: A systematic review by the GRAPPA nail psoriasis work groupJournal of Rheumatology
Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement networkPharmacoepidemiology and Drug Safety
Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: A cohort studyAnnals of Internal Medicine
Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: A longitudinal cohort studyAnnals of the Rheumatic Diseases
[Research at Landspitali University Hospital - comparison with the Nordic countries and new opportunities].Laeknabladid
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: A UK population-based cohort studyRheumatology (United Kingdom)

2013

Prevalence and treatment patterns of psoriatic arthritis in the UKRheumatology (United Kingdom)

2012

Psoriatic arthritis and onycholysis - Results from the cross-sectional reykjavik psoriatic arthritis studyJournal of Rheumatology
Obesity and the risk of psoriatic arthritis: A population-based studyAnnals of the Rheumatic Diseases
Borrelia and subsequent risk of solid tumors and hematologic malignancies in SwedenInternational Journal of Cancer
Re: Risk of malignancy associated with Lyme disease: Still up in the airInternational Journal of Cancer

2011

Validation of Psoriatic Arthritis Diagnoses in Electronic Medical Records Using Natural Language ProcessingSeminars in Arthritis and Rheumatism
Prevalence of the metabolic syndrome in psoriasis: Results from the national health and nutrition examination survey, 2003-2006Archives of Dermatology

2010

Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasisAnnals of the Rheumatic Diseases
Small joint involvement in psoriatic arthritis is associated with onycholysis: The reykjavik psoriatic arthritis studyScandinavian Journal of Rheumatology

2009

A 'pilot' study on air-travel and venous thromboembolismBritish Journal of Haematology
A strong heritability of psoriatic arthritis over four generations--the Reykjavik Psoriatic Arthritis Study.Rheumatology (Oxford, England)

2008

The relationship between cancer and rheumatoid arthritis: Still a large research agendaArthritis Research and Therapy

2007

Psoriatic arthritis in Reykjavik, Iceland: Prevalence, demographics, and disease courseJournal of Rheumatology

2004

Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8 + T cellsClinical and Experimental Immunology

Keywords for Specialisation:

Psoriatic arthritis

Database research